Upstream engineering to intelligent biomanufacturing

AMSP supports biotechnology teams in optimizing and scaling bioprocesses through consulting and engineering insights for TJX Bioengineering.

Core Capabilities

Three focus areas

We bridge the gap between benchtop biology and commercial yield by integrating expert consulting, secure AI modeling, and next-generation hardware.

Bioprocess Consulting

AMSP-LAST Platform

TJX Bioengineering

Rigorous upstream development, vessel characterization, and tech transfer documentation to optimize your cell line's metabolic performance.

A secure, local AI platform concept designed to model mass transfer coefficients and simulate scale-up physics without exposing proprietary data.

Exclusive business development and technical support for TJX bioreactor technologies across Europe and the Nordic region.

Target Ecosystems

Who we support

We partner with organizations requiring absolute precision in upstream scale-up. From high-growth startups to established CDMOs, our engineering frameworks adapt to your specific biological and physical constraints.

The AMSP Advantage

Thorough Scale-Up Engineering

We replace empirical trial-and-error with deterministic modeling, bridging the gap between molecular biology and industrial fluid dynamics.

Biology + Engineering

Scale-Up Focus

Data-Aware Modeling

Commercial Bridge

We balance cellular kinetics with physical bioreactor constraints, ensuring metabolic pathways survive structural shear stress.

Predictive modeling of vessel geometries from benchtop to production, minimizing yield loss during tech transfer.

Leveraging local machine learning models to analyze process parameters while keeping proprietary run data fully offline.

AMSP connects product value with customer needs in the European bioprocess market.

Mitigate Risks in Your Scaling Efforts

Engage with our engineering team to explore advanced upstream development, TJX bioreactor integration, or secure AI process modeling.